Which statement about biocompatibility testing is false?

• A. It assesses tissue compatibility of materials with biological systems.
• B. Cytotoxicity testing is a common biocompatibility test.
• C. Irritation/sensitization testing may be included.
• D. Biocompatibility testing guarantees device performance in all patient populations.

Answer: (D)

Biocompatibility testing looks at how a material or device interacts with the body, focusing on safety and how tissues respond rather than on how well the device functions. It assesses tissue compatibility to ensure the material won’t trigger harmful reactions. Cytotoxicity testing is a common part of this process because it checks whether any substances released by the material could kill cells or disrupt cellular function. Irritation or sensitization testing may also be included to evaluate potential inflammatory or allergic responses at the contact site. But biocompatibility testing cannot guarantee device performance in all patient populations. Individual differences in biology, anatomy, disease state, and implantation site, along with long-term effects, sterilization impacts, and mechanical performance, mean safety testing covers defined conditions and populations rather than universal device performance.